METTL3 and non-small cell lung carcinoma: miR-4443 is significantly up-regulated in exosomes released from cisplatin-resistant NSCLC tumors, resulting in a decrease in the expression of methyltransferase 3 (METTL3) in cisplatin-resistant A549 cells, thereby enhancing the expression of FSP1.